Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
18
Number of overlapping holdings
48.6%
% of BHCHX's 40 holdings also in IXJ
16.1%
% of IXJ's 112 holdings also in BHCHX
Overlap by Weight
Sector Drift (BHCHX minus IXJ)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BHCHX |
Weight in IXJ |
Overlap | |
---|---|---|---|---|
ELI LILLY AND COMPANY | 9.3% | 8.6% | 8.6% | |
UNITEDHEALTH GROUP INCORPORATED | 7.3% | 6.9% | 6.9% | |
MERCK & CO., INC. | 4.8% | 3.4% | 3.4% | |
THERMO FISHER SCIENTIFIC INC | 4.7% | 2.8% | 2.8% | |
INTUITIVE SURGICAL, INC. | 5.8% | 2.4% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
BHCHX Overweight Relative to IXJ
ARGENX SE ADR | 4.1% | |
BOSTON SCIENTIFIC CORP | 3.7% | |
BOSTON SCIENTIFIC CORPORATION | 3.7% | |
INTUITIVE SURGICAL INC | 3.4% | |
INTUITIVE SURGICAL, INC. | 3.4% | |
ICON PLC | 3.2% | |
VERTEX PHARMACEUTICALS INCORPORATED | 3.0% | |
VERTEX PHARMACEUTICALS INC | 3.0% | |
ARCELLX, INC. | 2.6% | |
THE COOPER COMPANIES, INC. | 2.3% |
BHCHX Underweight Relative to IXJ
JOHNSON & JOHNSON | -4.8% | |
ABBVIE INC | -4.8% | |
NOVO NORDISK A/S-B | -4.7% | |
ROCHE HOLDING LTD | -2.9% | |
ASTRAZENECA PLC | -2.9% | |
NOVARTIS AG | -2.9% | |
ABBOTT LABORATORIES | -2.7% | |
AMGEN INC | -2.3% | |
PFIZER INC | -2.1% | |
SANOFI-AVENTIS | -1.6% |